PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta-analysis.

PIK3CA mutations frequently occur in breast cancer patients. This study was conducted to evaluate the relationship between PIK3CA mutations and neoadjuvant treatment response and to analyze the clinical implications.